BeStock  
Stocks › Biotechnology › IMVT

Immunovant IMVT

US equityMarket cap rank #1778Biotechnology
$31.77 −$0.75 (-2.31%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $31.51 -0.82%
Open$32.26
Prev close$32.52
Day range$31.61 – $32.77
Volume704.9K
Market cap$6.57B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$48.43+52.4% vs. price
  • Buy 75%
  • Hold 25%
Low $37.00Now $31.77Avg $48.43High $66.00

Recent rating changes

The last 20 actions on file set price targets from $37.00 to $66.00, averaging $48.58.

DateFirmRatingTarget
12 Nov 2026 J.P. Morgan BUY $49.00
10 Nov 2026 Wells Fargo BUY $47.00
10 Nov 2026 H.C. Wainwright BUY $41.00
9 Nov 2026 Wells Fargo BUY $47.00
9 Nov 2026 BofA Securities BUY $46.00
16 Oct 2026 Wells Fargo BUY $45.00
12 Oct 2026 BofA Securities BUY $45.00
26 Sep 2026 LifeSci Capital BUY $53.00
25 Sep 2026 Bernstein HOLD $37.00
24 Sep 2026 Truist Financial HOLD –
23 Sep 2026 LifeSci Capital BUY $53.00
23 Sep 2026 H.C. Wainwright BUY $41.00
21 Sep 2026 Piper Sandler BUY $66.00
11 Aug 2026 Stifel BUY $57.00
10 Aug 2026 H.C. Wainwright BUY $41.00
10 Aug 2026 J.P. Morgan BUY $50.00
7 Aug 2026 LifeSci Capital BUY $53.00
7 Aug 2026 Piper Sandler BUY $66.00
7 Aug 2026 BofA Securities BUY $45.00
7 Aug 2026 H.C. Wainwright BUY $41.00

Discussion

No comments yet — be the first to weigh in on IMVT.

Sign in to join the discussion.

Scroll to Top